Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery

Santhi Gorantla, Huanyu Dou, Michael Boska, Christopher J. Destache, Jay Nelson, Larisa Poluektova, Barett E. Rabinow, Howard E. Gendelman, R. Lee Mosley

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

We posit that the same mononuclear phagocytes (MP) [bone marrow (BM) and blood monocytes, tissue macrophages, microglia, and dendritic cells] which serve as targets, reservoirs, and vehicles for HIV dissemination, can be used as vehicles for antiretroviral therapy (ART). Toward this end, BM macrophages (BMM) were used as carriers for nanoparticle-formulated indinavir (NP-IDV), and the cell distribution was monitored by single photon emission computed tomography (SPECT), transverse relation time (T2)* weighted magnetic resonance imaging (MRI), histology, and γ-scintillation spectrometry. BMM labeled with super paramagnetic iron oxide and/or 111indium oxine were infused i.v. into naïve mice. During the first 7 h, greater than 86% of cell label was recorded within the lungs. On Days 1, 3, 5, and 7, less than 10% of BMM were in lungs, and 74-81% and 13-18% were in liver and spleen, respectively. On a tissue volume basis, as determined by SPECT and MRI, BMM densities in spleen and liver were significantly greater than other tissues. Migration into the lymph nodes on Days 1 and 7 accounted for 1.5-2% of the total BMM. Adoptive transfer of BMM loaded with NP-IDV produced drug levels in lymphoid and nonlymphoid tissues that exceeded reported therapeutic concentrations by 200- to 350-fold on Day 1 and remained in excess of 100- to 300-fold on Day 14. These data show real-time kinetics and destinations of macrophage trafficking and demonstrate the feasibility of monitoring macrophage-based, nanoformulated ART.

Original languageEnglish
Pages (from-to)1165-1174
Number of pages10
JournalJournal of Leukocyte Biology
Volume80
Issue number5
DOIs
StatePublished - Nov 2006

Fingerprint

Single-Photon Emission-Computed Tomography
Magnetic Resonance Spectroscopy
Macrophages
Pharmaceutical Preparations
Indinavir
Nanoparticles
Spleen
Bone Marrow
Magnetic Resonance Imaging
Oxyquinoline
Lung
Adoptive Transfer
Liver
Microglia
Lymphoid Tissue
Phagocytes
Dendritic Cells
Monocytes
Spectrum Analysis
Histology

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery. / Gorantla, Santhi; Dou, Huanyu; Boska, Michael; Destache, Christopher J.; Nelson, Jay; Poluektova, Larisa; Rabinow, Barett E.; Gendelman, Howard E.; Mosley, R. Lee.

In: Journal of Leukocyte Biology, Vol. 80, No. 5, 11.2006, p. 1165-1174.

Research output: Contribution to journalArticle

Gorantla, S, Dou, H, Boska, M, Destache, CJ, Nelson, J, Poluektova, L, Rabinow, BE, Gendelman, HE & Mosley, RL 2006, 'Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery', Journal of Leukocyte Biology, vol. 80, no. 5, pp. 1165-1174. https://doi.org/10.1189/jlb.0206110
Gorantla, Santhi ; Dou, Huanyu ; Boska, Michael ; Destache, Christopher J. ; Nelson, Jay ; Poluektova, Larisa ; Rabinow, Barett E. ; Gendelman, Howard E. ; Mosley, R. Lee. / Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery. In: Journal of Leukocyte Biology. 2006 ; Vol. 80, No. 5. pp. 1165-1174.
@article{a48fcba6552d48a89bab2de9a96388e1,
title = "Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery",
abstract = "We posit that the same mononuclear phagocytes (MP) [bone marrow (BM) and blood monocytes, tissue macrophages, microglia, and dendritic cells] which serve as targets, reservoirs, and vehicles for HIV dissemination, can be used as vehicles for antiretroviral therapy (ART). Toward this end, BM macrophages (BMM) were used as carriers for nanoparticle-formulated indinavir (NP-IDV), and the cell distribution was monitored by single photon emission computed tomography (SPECT), transverse relation time (T2)* weighted magnetic resonance imaging (MRI), histology, and γ-scintillation spectrometry. BMM labeled with super paramagnetic iron oxide and/or 111indium oxine were infused i.v. into na{\"i}ve mice. During the first 7 h, greater than 86{\%} of cell label was recorded within the lungs. On Days 1, 3, 5, and 7, less than 10{\%} of BMM were in lungs, and 74-81{\%} and 13-18{\%} were in liver and spleen, respectively. On a tissue volume basis, as determined by SPECT and MRI, BMM densities in spleen and liver were significantly greater than other tissues. Migration into the lymph nodes on Days 1 and 7 accounted for 1.5-2{\%} of the total BMM. Adoptive transfer of BMM loaded with NP-IDV produced drug levels in lymphoid and nonlymphoid tissues that exceeded reported therapeutic concentrations by 200- to 350-fold on Day 1 and remained in excess of 100- to 300-fold on Day 14. These data show real-time kinetics and destinations of macrophage trafficking and demonstrate the feasibility of monitoring macrophage-based, nanoformulated ART.",
author = "Santhi Gorantla and Huanyu Dou and Michael Boska and Destache, {Christopher J.} and Jay Nelson and Larisa Poluektova and Rabinow, {Barett E.} and Gendelman, {Howard E.} and Mosley, {R. Lee}",
year = "2006",
month = "11",
doi = "10.1189/jlb.0206110",
language = "English",
volume = "80",
pages = "1165--1174",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "5",

}

TY - JOUR

T1 - Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery

AU - Gorantla, Santhi

AU - Dou, Huanyu

AU - Boska, Michael

AU - Destache, Christopher J.

AU - Nelson, Jay

AU - Poluektova, Larisa

AU - Rabinow, Barett E.

AU - Gendelman, Howard E.

AU - Mosley, R. Lee

PY - 2006/11

Y1 - 2006/11

N2 - We posit that the same mononuclear phagocytes (MP) [bone marrow (BM) and blood monocytes, tissue macrophages, microglia, and dendritic cells] which serve as targets, reservoirs, and vehicles for HIV dissemination, can be used as vehicles for antiretroviral therapy (ART). Toward this end, BM macrophages (BMM) were used as carriers for nanoparticle-formulated indinavir (NP-IDV), and the cell distribution was monitored by single photon emission computed tomography (SPECT), transverse relation time (T2)* weighted magnetic resonance imaging (MRI), histology, and γ-scintillation spectrometry. BMM labeled with super paramagnetic iron oxide and/or 111indium oxine were infused i.v. into naïve mice. During the first 7 h, greater than 86% of cell label was recorded within the lungs. On Days 1, 3, 5, and 7, less than 10% of BMM were in lungs, and 74-81% and 13-18% were in liver and spleen, respectively. On a tissue volume basis, as determined by SPECT and MRI, BMM densities in spleen and liver were significantly greater than other tissues. Migration into the lymph nodes on Days 1 and 7 accounted for 1.5-2% of the total BMM. Adoptive transfer of BMM loaded with NP-IDV produced drug levels in lymphoid and nonlymphoid tissues that exceeded reported therapeutic concentrations by 200- to 350-fold on Day 1 and remained in excess of 100- to 300-fold on Day 14. These data show real-time kinetics and destinations of macrophage trafficking and demonstrate the feasibility of monitoring macrophage-based, nanoformulated ART.

AB - We posit that the same mononuclear phagocytes (MP) [bone marrow (BM) and blood monocytes, tissue macrophages, microglia, and dendritic cells] which serve as targets, reservoirs, and vehicles for HIV dissemination, can be used as vehicles for antiretroviral therapy (ART). Toward this end, BM macrophages (BMM) were used as carriers for nanoparticle-formulated indinavir (NP-IDV), and the cell distribution was monitored by single photon emission computed tomography (SPECT), transverse relation time (T2)* weighted magnetic resonance imaging (MRI), histology, and γ-scintillation spectrometry. BMM labeled with super paramagnetic iron oxide and/or 111indium oxine were infused i.v. into naïve mice. During the first 7 h, greater than 86% of cell label was recorded within the lungs. On Days 1, 3, 5, and 7, less than 10% of BMM were in lungs, and 74-81% and 13-18% were in liver and spleen, respectively. On a tissue volume basis, as determined by SPECT and MRI, BMM densities in spleen and liver were significantly greater than other tissues. Migration into the lymph nodes on Days 1 and 7 accounted for 1.5-2% of the total BMM. Adoptive transfer of BMM loaded with NP-IDV produced drug levels in lymphoid and nonlymphoid tissues that exceeded reported therapeutic concentrations by 200- to 350-fold on Day 1 and remained in excess of 100- to 300-fold on Day 14. These data show real-time kinetics and destinations of macrophage trafficking and demonstrate the feasibility of monitoring macrophage-based, nanoformulated ART.

UR - http://www.scopus.com/inward/record.url?scp=33750436256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750436256&partnerID=8YFLogxK

U2 - 10.1189/jlb.0206110

DO - 10.1189/jlb.0206110

M3 - Article

C2 - 16908517

AN - SCOPUS:33750436256

VL - 80

SP - 1165

EP - 1174

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 5

ER -